NOMV are actively being considered as vaccines against meningococcal disease (van der Ley and van den Dobbelsteen, 2011), we therefore wanted to understand how a further modification may impact on human DC and T-cell responses
NOMV are actively being considered as vaccines against meningococcal disease (van der Ley and van den Dobbelsteen, 2011), we therefore […]